Molecular rationale for the impairment of the MexAB-OprM efflux pump by a single mutation in MexA
- PMID: 35024097
- PMCID: PMC8717590
- DOI: 10.1016/j.csbj.2021.11.042
Molecular rationale for the impairment of the MexAB-OprM efflux pump by a single mutation in MexA
Abstract
Efflux pumps of the Resistance-Nodulation-cell Division (RND) superfamily contribute to intrinsic and acquired resistance in Gram-negative pathogens by expelling chemically unrelated antibiotics with high efficiency. They are tripartite systems constituted by an inner-membrane-anchored transporter, an outer membrane factor protein, and a membrane fusion protein. Multimerization of the membrane fusion protein is an essential prerequisite for full functionality of these efflux pumps. In this work, we employed complementary computational techniques to investigate the stability of a dimeric unit of MexA (the membrane fusion protein of the MexAB-OprM RND efflux pump of Pseudomonas aeruginosa), and to provide a molecular rationale for the effect of the G72S substitution, which affects MexAB-OprM functionality by impairing the assembly of MexA. Our findings indicate that: i) dimers of this protein are stable in multiple µs-long molecular dynamics simulations; ii) the mutation drastically alters the conformational equilibrium of MexA, favouring a collapsed conformation that is unlikely to form dimers or higher order assemblies. Unveiling the mechanistic aspects underlying large conformational distortions induced by minor sequence changes is informative to efforts at interfering with the activity of this elusive bacterial weapon. In this respect, our work further confirms how molecular simulations can give important contribution and useful insights to characterize the mechanism of highly complex biological systems.
Keywords: Bacterial resistance; Molecular docking; Molecular dynamics; Protein structure and dynamics; RND efflux pumps.
© 2021 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





References
-
- Årdal C., Baraldi E., Ciabuschi F., Outterson K., Rex J.H., Piddock L.J.V., et al. To the G20: incentivising antibacterial research and development. Lancet Infect Dis. 2017;17(8):799–801. - PubMed
-
- World Health Organization, Global antimicrobial resistance and use surveillance system (GLASS) report 2021 (2021). Geneva, Switzerland (https://www.who.int/publications/i/item/9789240027336).
Grants and funding
LinkOut - more resources
Full Text Sources